title: Treatment of human granulocytic ehrlichiosis during pregnancy and risk of perinatal transmission.
abstract: A pregnant woman from Nantucket Island, MA was diagnosed with human granulocytic ehrlichiosis at 34 weeks gestation. We describe the diagnostic and therapeutic dilemmas involved and discuss the risks of perinatal transmission.
authors.affiliation: Beth Israel Deaconess Medical Center, Division of Infectious Diseases, Harvard Medical School, Boston, MA, USA. nathalie.casau@nbhn.net
authors.forename: Nathalie C
authors.initials: NC
authors.lastname: Casau
authors.forename: Mary Ellen
authors.initials: ME
authors.lastname: Hewins
authors.forename: Dori F
authors.initials: DF
authors.lastname: Zaleznik
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001942:Breast Feeding; D004318:Doxycycline / Q000627:therapeutic use; D016873:Ehrlichiosis / Q000188:drug therapy* / Q000635:transmission*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D004318:Doxycycline